Cargando…

Early Adjuvant Medication With the mTOR Inhibitor Sirolimus in a Preterm Neonate With Compressive Cystic Lymphatic Malformation

Cystic lymphatic malformations result from an abnormal embryological development of the lymphatic structures. Here we report on a case of a preterm female baby, born at 34 weeks of gestation, with a voluminous cervicofacial cystic lymphatic malformation responsible for an airway obstruction. An mTOR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honnorat, Marion, Viremouneix, Loïc, Ayari, Sonia, Guibaud, Laurent, Coste, Karen, Claris, Olivier, Butin, Marine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399047/ https://www.ncbi.nlm.nih.gov/pubmed/32850534 http://dx.doi.org/10.3389/fped.2020.00418

Ejemplares similares

Efficacy of sirolimus in children with lymphatic malformations of the head and neck
por: Wiegand, S., et al.
Publicado: (2022)

Sirolimus: A Successful Medical Treatment for Head and Neck Lymphatic Malformations
por: Curry, Steven, et al.
Publicado: (2019)

Sirolimus treatment for paediatric head and neck lymphatic malformations: a systematic review
por: Saibene, Alberto Maria, et al.
Publicado: (2023)

Rapid response with good toleration of sirolimus for life‐threatening neonatal lymphatic malformations
por: Dong, Shixiao, et al.
Publicado: (2023)

Refractory Head and Neck Lymphatic Malformation in Infants Treated With Sirolimus: A Case Series
por: Wu, Changhua, et al.
Publicado: (2021)

Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis
por: Gao, Hui, et al.
Publicado: (2023)

Correction: Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis
Publicado: (2023)

French national diagnosis and care protocol (PNDS, protocole national de diagnostic et de soins): cystic lymphatic malformations
por: Leboulanger, Nicolas, et al.
Publicado: (2023)

Lymphatic Malformation Responsive to Sirolimus in Keratinocytic Epidermal Nevus Syndrome with KRAS Mutation: A Case and Brief Literature Discussion
por: Sideris, Emily, et al.
Publicado: (2021)

The Effectiveness of Sirolimus Treatment in Two Rare Disorders with Nonketotic Hypoinsulinemic Hypoglycemia: The Role of mTOR Pathway
por: Şıklar, Zeynep, et al.
Publicado: (2020)

Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab
por: Mulot, Gwenaelle, et al.
Publicado: (2022)

Cystic mass of the right iliac fossa: don't forget about lymphatic malformation
por: Bellamlih, Habib, et al.
Publicado: (2020)

Cystic Lymphatic Malformation with Lymphedema Treated by Lymphaticovenular Anastomosis Combined with Ethanol Sclerotherapy
por: Yoshida, Shuhei, et al.
Publicado: (2023)

Topical sirolimus 0.1% for treating cutaneous microcystic lymphatic malformations in children and adults (TOPICAL): protocol for a multicenter phase 2, within-person, randomized, double-blind, vehicle-controlled clinical trial
por: Leducq, Sophie, et al.
Publicado: (2019)

Efficacy of Sirolimus in Patients Requiring Tracheostomy for Life-Threatening Lymphatic Malformation of the Head and Neck: A Report From the European Reference Network
por: Holm, Annegret, et al.
Publicado: (2021)

Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy
por: Park, Haeseong, et al.
Publicado: (2016)

Lymphatic Malformations of the Orbit
por: Wiegand, Susanne, et al.
Publicado: (2013)

Lymphatic Malformation Treated with Lymphatic Malformation–Venous Anastomosis Under Local Anesthesia
por: Furuse, Kiichi, et al.
Publicado: (2020)

Phase I study and preclinical efficacy evaluation of the mTOR inhibitor sirolimus plus gemcitabine in patients with advanced solid tumours
por: Martin-Liberal, J, et al.
Publicado: (2014)

Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression
por: Bak, Szilvia, et al.
Publicado: (2018)

Aberrant Lymphatic Endothelial Progenitors in Lymphatic Malformation Development
por: Wu, June K., et al.
Publicado: (2015)

Inflow Occlusion Combined With Bleomycin Sclerotherapy for Management of Macro/Mixed Cystic Lymphatic Malformation in Children
por: Han, Tao, et al.
Publicado: (2021)

Percutaneous Lauromacrogol Foam Sclerotherapy for the Treatment of Acute Airway Compression Caused by Lymphatic Malformations in Infants
por: Wang, Lidan, et al.
Publicado: (2018)

Lymphatic Malformations: Current Status
por: Khunger, Niti
Publicado: (2010)

Sclerotherapy in Lymphatic Malformations with Intralesional Hemorrhage: A Retrospective Comparison with Non-Hemorrhagic Lymphatic Malformations
por: Wang, Wenjing, et al.
Publicado: (2022)

A Case of Suspected Adverse Reactions to Sirolimus in the Treatment of Generalized Lymphatic Anomaly
por: Fujii, Takayuki, et al.
Publicado: (2019)

Monitoring of sirolimus in the whole blood samples from pediatric patients with lymphatic anomalies
por: Treder, Natalia, et al.
Publicado: (2023)

Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation
por: Abdelbaky, Mohamed Aly, et al.
Publicado: (2020)

Large Cystic Mass of the Pancreatico-Duodenal Region Revealing Duodenal Lymphatic Malformation: A Case Report
por: Belkouchi, Lina, et al.
Publicado: (2022)

Increasing use of linezolid in a tertiary NICU during a 10-year period: reasons and concerns for the future
por: Matrat, Lucie, et al.
Publicado: (2020)

Retroperitoneal lymphatic malformation in a dog
por: Driessen, Floor, et al.
Publicado: (2020)

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
por: Reilly, R., et al.
Publicado: (2017)

Abstract: Successful Treatment of a Complex Vascular Malformation with Sirolimus and Surgical Resection
por: Carvas, Marcelo, et al.
Publicado: (2016)

Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus
por: Harbers, Veroniek E. M., et al.
Publicado: (2021)

Sirolimus for the Management of Verrucous Venous Malformation: A Case Report and Literature Review
por: Al-Furaih, Ibrahim, et al.
Publicado: (2021)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Outcome of Sclerotherapy in a Preterm Infant with a Giant Fetal Neck Lymphatic Malformation: A Case Report
por: Zeng, Zhaomin, et al.
Publicado: (2023)

RHEB/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity
por: Proietti Onori, Martina, et al.
Publicado: (2021)

SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation
por: Mercier, Julia, et al.
Publicado: (2022)

Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial
por: Marchand, A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r75cniophlmglpg41co18sgefl